Section for Studies on Metastasis, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
J Biol Chem. 2010 Jun 4;285(23):17442-52. doi: 10.1074/jbc.M110.107821. Epub 2010 Mar 30.
The existence of circulating microRNAs (miRNAs) in the blood of cancer patients has raised the possibility that miRNAs may serve as a novel diagnostic marker. However, the secretory mechanism and biological function of extracellular miRNAs remain unclear. Here, we show that miRNAs are released through a ceramide-dependent secretory machinery and that the secretory miRNAs are transferable and functional in the recipient cells. Ceramide, whose biosynthesis is regulated by neutral sphingomyelinase 2 (nSMase2), triggers secretion of small membrane vesicles called exosomes. The decreased activity of nSMase2 with a chemical inhibitor, GW4869, and a specific small interfering RNA resulted in the reduced secretion of miRNAs. Complementarily, overexpression of nSMase2 increased extracellular amounts of miRNAs. We also revealed that the endosomal sorting complex required for transport system is unnecessary for the release of miRNAs. Furthermore, a tumor-suppressive miRNA secreted via this pathway was transported between cells and exerted gene silencing in the recipient cells, thereby leading to cell growth inhibition. Our findings shed a ray of light on the physiological relevance of secretory miRNAs.
循环 microRNAs(miRNAs)在癌症患者血液中的存在提出了这样一种可能性,即 miRNAs 可能作为一种新的诊断标志物。然而,细胞外 miRNAs 的分泌机制和生物学功能仍不清楚。在这里,我们表明 miRNAs 通过神经酰胺依赖性分泌机制释放,并且分泌的 miRNA 在受体细胞中是可转移和有功能的。神经酰胺的生物合成受中性鞘磷脂酶 2(nSMase2)调节,触发小膜囊泡(称为外泌体)的分泌。化学抑制剂 GW4869 和特定的小干扰 RNA 降低 nSMase2 的活性会导致 miRNA 分泌减少。互补的是,nSMase2 的过表达会增加细胞外 miRNA 的数量。我们还揭示了内体分选复合物运输系统对于 miRNA 的释放不是必需的。此外,通过该途径分泌的肿瘤抑制 miRNA 在细胞间运输,并在受体细胞中发挥基因沉默作用,从而导致细胞生长抑制。我们的发现为分泌 miRNA 的生理相关性提供了一些线索。